Pioneer in introducing oral iron chelator (L1) for clinical research and application in Asia.Renowned internationally, serving as an Advisory Board Member for the International Thalassaemia Federation (T.I.F).Regularly invited to lecture globally and actively involved in international thalassemia research, contributing to the enhancement of care quality.As the Dean of the Children's Hospital (2009–2016), he strongly advocated for child-friendly healthcare and the protection of children's rights, elevating the hospital to international recognition.Appointed as Director of the Taiwan Childhood Cancer Foundation in 2019, promoting a goal of achieving a 100% cure rate for childhood cancers.President of the Taiwan Society on Thrombosis and Hemostasis since 2017, advancing treatment and research for bleeding disorders (e.g., hemophilia) and thrombotic diseases, aiming for equal quality of life for patients.
With over 30 years of clinical experience in pediatric hematology and oncology, he specializes in pediatric leukemia, tumors, anemia, purpura, and hemophilia.Has provided exceptional care for countless children in Central Taiwan, gaining the trust and admiration of families through his expertise and compassionate approach.Known for his warm demeanor and patient-centric care, frequently commended by families for his dedication and professionalism.
